A comparison between solvent casting and electrospinning methods for the fabrication of neem extract-containing buccal films
Source abstract
Abstract
In the present study a double layer mucoadhesive buccal film containing nanocarriers encapsulated with neem extract was fabricated through electrospinning and solvent casting techniques for dental therapeutic applications. The morphological, physical and mucoadhesive properties of the resulting electrospun and solvent cast oral films were mutually compared, and their drug release behavior and antibacterial activity were further investigated. Chitosan/poly(vinylalcohol) (PVA) as a mucoadhesive component and phenylalanine amino acid nanotubes (PhNTs)-containing neem extract as a drug nanocarrier were used to fabricate oral films. A poly(caprolactone) (PCL) layer was used as an impermeable backing layer to protect the mucoadhesive component from tongue movement and drug loss. The results indicated an interconnected porous and fully filled solid structures for electrospun and solvent cast films, respectively. The physicomechanical parameters of the samples such as pH, weight, thickness, folding endurance and tensile strength were also evaluated. The crosslinked electrospun buccal film indicated better swelling and mucoadhesive properties compared to the solvent cast film. In addition, the drug loading capacity and encapsulation efficiency of the solvent cast film showed lower experimental values than those of electrospun oral film. On the other hand, the electrospun oral film had a well-controlled release of neem extract up to 82% at oral pH, which is best fitted to the Weibull model, and demonstrated the highest antibacterial properties against S. mutans bacteria with high biocompatibility on L929 fibroblast cells. Generally, the synthesized electrospun mucoadhesive film has a better potential for oral therapeutic applications than the solvent cast film.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Advanced Drug Delivery Systems · Oral and gingival health research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Textile Engineering Department, Amirkabir University of Technology, Tehran, Iran
References (54)
Show source-provided references
1. 10.1016/B978-0-12-818831-6.00010-010.1016/B978-0-12-818831-6.00010-0 ↗
2. 10.1021/acs.molpharmaceut.9b0053510.1021/acs.molpharmaceut.9b00535 ↗
3. 10.1007/s13346-020-00814-410.1007/s13346-020-00814-4 ↗
4. 10.1016/j.jddst.2018.06.01810.1016/j.jddst.2018.06.018 ↗
5. 10.1016/j.bjan.2016.10.00610.1016/j.bjan.2016.10.006 ↗
6. 10.3390/pharmaceutics1103010410.3390/pharmaceutics11030104 ↗
7. 10.18433/J3FM0610.18433/J3FM06 ↗
8. 10.1155/2015/58014610.1155/2015/580146 ↗
9. 10.1016/j.eurpolymj.2019.07.01010.1016/j.eurpolymj.2019.07.010 ↗
10. 10.3390/pharmaceutics1207065710.3390/pharmaceutics12070657 ↗
11. 10.1016/B978-0-08-102491-1.00005-810.1016/B978-0-08-102491-1.00005-8 ↗
12. 10.1002/pat.429010.1002/pat.4290 ↗
13. 10.1007/s12221-014-1908-y10.1007/s12221-014-1908-y ↗
14. 10.3390/polym1003026710.3390/polym10030267 ↗
15. 10.1002/9781119459804.ch110.1002/9781119459804.ch1 ↗
16. 10.1016/j.msec.2012.05.00910.1016/j.msec.2012.05.009 ↗
17. 10.5772/6130010.5772/61300 ↗
18. 10.1016/j.biotechadv.2018.11.00810.1016/j.biotechadv.2018.11.008 ↗
19. Nasiri Zadeh S · Bioequival Bioavailabil · 2017 · 3 · 39
20. 10.1016/j.jconrel.2020.01.00610.1016/j.jconrel.2020.01.006 ↗
21. 10.1186/s12951-018-0392-810.1186/s12951-018-0392-8 ↗
22. 10.1021/nn506255e10.1021/nn506255e ↗
23. 10.1002/slct.20200328110.1002/slct.202003281 ↗
24. Botelho MA · J Medicinal Plants Res · 2008 · 2 · 341
25. Behl M · Neem Foundation · 2002 · 169
26. Naveed N · Research Journal of Pharmacy and Technology · 2014 · 7 · 1060
27. 10.9734/BJMMR/2017/3353810.9734/BJMMR/2017/33538 ↗
28. 10.1016/j.jff.2020.10417110.1016/j.jff.2020.104171 ↗
29. Lade Milind S, Payghan Santosh A, Tamboli Zaki J, et al. Polymer based wafer technology: a review. International Journal of Pharmaceutical & Biological Archives 2013; 4: 1060–1074.
30. 10.3390/pharmaceutics1205047010.3390/pharmaceutics12050470 ↗
31. 10.1007/s10924-016-0820-510.1007/s10924-016-0820-5 ↗
32. 10.1016/j.jsps.2015.02.02410.1016/j.jsps.2015.02.024 ↗
33. 10.15171/apb.2017.05310.15171/apb.2017.053 ↗
34. 10.1016/j.ijbiomac.2018.05.13010.1016/j.ijbiomac.2018.05.130 ↗
35. 10.1002/btpr.157610.1002/btpr.1576 ↗
36. 10.1080/15440478.2019.169112210.1080/15440478.2019.1691122 ↗
37. 10.5530/srp.2017.1.710.5530/srp.2017.1.7 ↗
38. 10.1038/s41598-018-23378-310.1038/s41598-018-23378-3 ↗
39. 10.5958/0975-4377.2019.00047.810.5958/0975-4377.2019.00047.8 ↗
40. 10.4103/2230-973X.8596710.4103/2230-973X.85967 ↗
41. Malik R · Artif Cells Nanomed Biotechnol · 2016 · 44 · 928
42. 10.1016/j.polymer.2018.10.02210.1016/j.polymer.2018.10.022 ↗
43. 10.24092/CRPS.2017.07010110.24092/CRPS.2017.070101 ↗
44. 10.1177/155892502098256910.1177/1558925020982569 ↗
45. Singh R · J Dev Drugs · 2017 · 6 · 1
46. 10.4103/0973-7847.15633710.4103/0973-7847.156337 ↗
47. 10.1517/1742524100360225910.1517/17425241003602259 ↗
48. 10.1007/s42242-019-00041-y10.1007/s42242-019-00041-y ↗
49. 10.1002/mabi.20200011510.1002/mabi.202000115 ↗
50. Jahromi LP · Heliyon · 2020 · 6 · e03451.10.1016/j.heliyon.2020.e03451 ↗
51. 10.1016/B978-0-08-100092-2.00005-910.1016/B978-0-08-100092-2.00005-9 ↗
52. 10.1016/j.ijpharm.2005.10.04410.1016/j.ijpharm.2005.10.044 ↗
53. Azadi S · J Appl Pharm Sci · 2017 · 7 · 125
54. Haque S · Biojournal Sci Technol · 2016 · 3 · 1